Data Collective IV GP, LLC - Stock Holdings in 13F Filings (SEC)
Updated on March 15, 2026.
Based on 13F Filings filed with the SEC on February 17, 2026, for the 2025 Q4 period, Data Collective IV GP, LLC held in its portfolio 3 assets valued at $58,507,268 (i.e. $58.51M).
The most valuable assets in the portfolio included: Evolv Technologies Holdings, Inc. ($32.86M), Recursion Pharmaceuticals, Inc. ($24.30M), and Mind Medicine (MindMed) Inc. ($1.34M).
The chart below shows the top 3 valuable assets, and the table below shows the top 3 valuable assets.
You can see similar for other investment managers.
Related Topics: SEC Topic List.
Data Source: SEC.
Data Collective IV GP, LLC - Stock Holdings in 13F Filings (SEC)
Items per page:
25
0 of 0
| Name of Issuer | No. of Shares | Value ($) | Class |
|---|---|---|---|
| Evolv Technologies Holdings, Inc. | 4590000 | 32864400 | COM CL A |
| Recursion Pharmaceuticals, Inc. | 5941120 | 24299181 | CL A |
| Mind Medicine (MindMed) Inc. | 100350 | 1343687 | COM NEW |